Oncology Tube Profiles Acceleration of Dosing in AVM NHL Clinical Trial
Oncology Tube highlights the FDA approval of accelerated dosing in AVM Biotechnology’s adaptive design expansion cohort clinical trial treating Non-Hodgkin’s Lymphoma/Leukemia.
Oncology Tube highlights the FDA approval of accelerated dosing in AVM Biotechnology’s adaptive design expansion cohort clinical trial treating Non-Hodgkin’s Lymphoma/Leukemia.